Interstital lung disease rates and risk factors in a UK lung cancer screening trial

T. Mikolasch (London, United Kingdom), M. Ruparel* (London, United Kingdom), J. Dickson (London, United Kingdom), C. Horst (London, United Kingdom), S. Tisi (London, United Kingdom), S. Quaife (London, United Kingdom), N. Navani (London, United Kingdom), M. Taylor (London, United Kingdom), A. Ahmed (London, United Kingdom), P. Shaw (London, United Kingdom), S. Burke (London, United Kingdom), M. Soo (London, United Kingdom), A. Bhowmik (London, United Kingdom), J. Porter (London, United Kingdom), S. Janes (London, United Kingdom)

Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Session: The world of idiopathic pulmonary fibrosis (IPF): global registries
Session type: Poster Discussion
Number: 2208
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Mikolasch (London, United Kingdom), M. Ruparel* (London, United Kingdom), J. Dickson (London, United Kingdom), C. Horst (London, United Kingdom), S. Tisi (London, United Kingdom), S. Quaife (London, United Kingdom), N. Navani (London, United Kingdom), M. Taylor (London, United Kingdom), A. Ahmed (London, United Kingdom), P. Shaw (London, United Kingdom), S. Burke (London, United Kingdom), M. Soo (London, United Kingdom), A. Bhowmik (London, United Kingdom), J. Porter (London, United Kingdom), S. Janes (London, United Kingdom). Interstital lung disease rates and risk factors in a UK lung cancer screening trial. 2208

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: